GlassScriptPhysician profile
Meredith M Berger
NPI 1831181734
$31,599.85
in general payments reported to CMS, 2019-2025
65 companies · $2,099 in 2025
The $2,099 reported for 2025 was more than what 77% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,835 · 2021: $1,717 · 2022: $2,544 · 2023: $2,276 · 2024: $2,709 · 2025: $2,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,070 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,070.16 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17,985.16 | 2019-2025 | |
| Lilly USA, LLC | $1,574.92 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Amgen INC. | $1,276.15 | 2019-2025 | Evenity, Prolia, Tepezza |
| Novo Nordisk INC | $1,153.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $812.04 | 2019-2025 | Freestyle Libre 3 |
| Insulet Corporation | $719.75 | 2019-2024 | Omnipod |
| Amneal Pharmaceuticals LLC | $576.32 | 2019-2025 | Unithroid |
| Radius Health, INC. | $529.81 | 2019-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $452.71 | 2022-2025 | |
| Ibsa Pharma INC. | $449.45 | 2019-2025 | Tirosint, Licart, Tirosint |
| Boehringer Ingelheim Pharmaceuticals, INC. | $445.17 | 2019-2025 | Jardiance, Synjardy |
| Astrazeneca Pharmaceuticals LP | $398.75 | 2019-2024 | Farxiga |
| Abbvie INC. | $395.75 | 2019-2024 | Synthroid, Ubrelvy |
| Antares Pharma, INC. | $388.88 | 2019-2025 | Xyosted |
| Xeris Pharmaceuticals, INC. | $370.86 | 2022-2025 | Gvoke Hypopen, Recorlev |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $268.95 | 2019-2024 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $248.94 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lifescan, INC. | $228.39 | 2019-2023 | |
| Recordati_rare_diseases_inc. | $214.59 | 2021-2025 | Isturisa, Signifor Lar |
| Medtronic, INC. | $210.02 | 2022-2024 | Minimed 780g |
| Merck Sharp & Dohme LLC | $195.06 | 2019-2023 | Januvia, Steglujan, Steglatro |
| Amarin Pharma, INC. | $180.39 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.29 | 2021-2025 | |
| Mannkind Corporation | $156.33 | 2020-2025 | |
| Esperion Therapeutics, INC. | $154.94 | 2021-2024 | Nexletol |
| Tolmar, INC. | $149.18 | 2023-2025 | Jatenzo |
| Pfizer INC. | $141.27 | 2019-2025 | |
| Cequr Corporation | $133.25 | 2023-2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $121.64 | 2019-2023 | Tepezza |
| Shire North American Group INC | $110.87 | 2019 | |
| Ascendis Pharma Endocrinology INC | $99.49 | 2023-2025 | Yorvipath |
| Sequel Med Tech, LLC | $96.67 | 2025 | Twiist |
| Clarus Therapeutics INC. | $86.22 | 2021 | |
| Astellas Pharma US INC | $82.06 | 2023-2025 | Veozah |
| Currax Pharmaceuticals LLC | $71.35 | 2019-2024 | Contrave |
| Alexion Pharmaceuticals, INC. | $58.78 | 2019-2025 | Strensiq |
| Janssen Pharmaceuticals, INC | $52.37 | 2019-2020 | |
| Beta Bionics, INC. | $51.90 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ultragenyx Pharmaceutical INC. | $51.27 | 2019-2022 | |
| Averitas Pharma INC. | $48.34 | 2025 | Qutenza |
| Kyowa Kirin, INC. | $47.62 | 2023-2024 | Crysvita |
| Nevro Corp. | $46.52 | 2023 | Senza |
| Medtronic Minimed, INC. | $40.74 | 2019 | |
| Boston Scientific Corporation | $40.34 | 2024-2025 | General - Pain Management |
| Valeritas, INC. | $37.51 | 2019 | |
| Corcept Therapeutics | $37.20 | 2024 | Korlym |
| Amag Pharmaceuticals, INC. | $36.30 | 2019 | |
| Metuchen Pharmaceuticals | $34.97 | 2019 | |
| Zealand Pharma US, INC. | $33.60 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $31.97 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.80 | 2022 | |
| Inspire Medical Systems, INC. | $30.31 | 2024 | Inspire |
| Madrigal Pharmaceuticals | $25.16 | 2025 | Rezdiffra |
| Neurocrine Biosciences, INC. | $22.04 | 2025 | |
| Soleno Therapeutics, INC. | $20.98 | 2025 | Vykat Xr |
| Acella Pharmaceuticals, LLC | $20.34 | 2024 | NP Thyroid 60 |
| Ipsen Biopharmaceuticals, INC | $19.05 | 2021 | |
| Vifor Pharma, INC. | $17.92 | 2019 | |
| Eusa Pharma (US) LLC | $17.92 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $17.78 | 2019 | |
| Amryt Pharma Holdings LTD | $16.94 | 2021 | |
| Vistapharm, INC. | $15.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.84 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.74 | 2019 | |
| Aytu Biopharma, INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.